How do you approach mood stabilizer selection for older adults with bipolar II disorder?  

When do you pursue dose reduction versus medication discontinuation versus switching agents in this population? How do you weigh risks of mood stabilizers and antipsychotics such as cognitive slowing, metabolic effects, EPS, or electrolyte disturbances?